Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry.
about
Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular systemSumatriptan elicits both constriction and dilation in human and bovine brain intracortical arteriolesStructure and function of serotonin G protein-coupled receptors.Intranasal Pharmacokinetic Data for Triptans Such as Sumatriptan and Zolmitriptan Can Render Area Under the Curve (AUC) Predictions for the Oral Route: Strategy Development and Application.Human cerebrovascular contractile receptors are upregulated via a B-Raf/MEK/ERK-sensitive signaling pathway.The trigeminovascular system in bacterial meningitis.Male-female differences in upregulation of vasoconstrictor responses in human cerebral arteries.Molecular cloning, sequence analysis and pharmacological properties of the porcine 5-HT(1D) receptor5-HT1B-receptors and vascular reactivity in human isolated blood vessels: assessment of the potential craniovascular selectivity of sumatriptan.Serotonin and blood pressure regulation.The blood-brain barrier in migraine treatment.Animal models of headache: from bedside to bench and back to bedside.5-HT(1F) Receptor agonists: a new treatment option for migraine attacks?Vascular plasticity in cerebrovascular disorders.Dihydroergotamine: a review of formulation approaches for the acute treatment of migraine.Headache, cerebral aneurysms, and the use of triptans and ergot derivatives.A model-based approach to treatment comparison in acute migraine.Involvement of 5-HT1B and 5-HT1D receptors in sumatriptan mediated vasocontractile response in rabbit common carotid artery.Vasomotor effects of acetylcholine, bradykinin, noradrenaline, 5-hydroxytryptamine, histamine and angiotensin II on the mouse basilar artery5-HT moduline: an endogenous inhibitor of 5-HT(1B/1D)-mediated contraction in pulmonary arteries.The effect of rizatriptan, ergotamine, and their combination on human peripheral arteries: a double-blind, placebo-controlled, crossover study in normal subjects.Triptans and CGRP blockade - impact on the cranial vasculature.Agonist-directed trafficking explaining the difference between response pattern of naratriptan and sumatriptan in rabbit common carotid artery.Vascular effects of the new anti-migraine agent almotriptan on human cranial and peripheral arteries.Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization.Effects of donitriptan on carotid haemodynamics and cardiac output distribution in anaesthetized pigs.5-Hydroxytryptamine(1B/1D) and 5-hydroxytryptamine1F receptors inhibit capsaicin-induced c-fos immunoreactivity within mouse trigeminal nucleus caudalis.Preclinical studies characterizing the anti-migraine and cardiovascular effects of the selective 5-HT1D receptor agonist PNU-142633.Secondhand cigarette smoke exposure causes upregulation of cerebrovascular 5-HT(1) (B) receptors via the Raf/ERK/MAPK pathway in rats.ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ET(B) and 5-HT(1B) receptor upregulation after subarachnoid hemorrhage in rat.Gene expression profiling in the human middle cerebral artery after cerebral ischemia.Investigation of the mechanisms mediating MDMA "Ecstasy"-induced increases in cerebro-cortical perfusion determined by btASL MRI.Protein kinase C inhibition prevents upregulation of vascular ET(B) and 5-HT(1B) receptors and reverses cerebral blood flow reduction after subarachnoid haemorrhage in rats.Migraine aggravation caused by cephalic venous congestion.The effect of sumatriptan on cephalic arteries: A 3T MR-angiography study in healthy volunteers
P2860
Q24646305-F84C81D4-0EFC-49F1-BBC3-607C69718358Q28345813-6A6ECD3A-664C-4A74-942F-0785F2AE0E7CQ30382524-F4D6935A-172F-4ED0-BFCE-E2E472ED9417Q31044224-9889D46B-01CA-4BFD-9B57-BFFC99E3E757Q33790457-96BBF35D-02EC-40DF-83E0-AEC8C7DC4131Q34218327-C237641F-4CEE-4020-BDCA-FC59B10DC258Q34712164-2347332E-ED0A-4DD0-B350-9AC2E52C77C3Q35042842-F88E4FB8-BE10-4FBE-BB38-DE98B8E5FBBDQ35803690-1562EFAC-9625-4DA7-945F-4F48DB1BE6DAQ35847080-35DD97F6-F4D1-4E99-B328-2AE5A2EA6172Q37252452-26EC1262-27AF-4876-8CF1-3C0566B96314Q37699421-E1D27967-4761-4F5B-BB60-5B33063BB899Q37739587-3D50EC77-9ACB-4F52-BB42-21DDE2301EEDQ37874109-34F2C070-A871-4377-91D7-DEE392B57076Q38101880-E465CC85-F12B-430D-8EF9-E1E32C1917D0Q38436592-BC28ACCA-323E-4001-B68B-9F2AB80E42E6Q39344317-3A0F0618-180F-451B-B564-F1042C2B782CQ41840257-6809E8C1-7823-4CD6-8D71-7A1DE0EB7740Q41905257-58B521B5-1569-4373-A3FB-BFB0968A40DEQ41972338-73714863-0CAF-4A16-8A39-E0DAD9601F3CQ42081184-6F5276BB-8331-4464-826D-29DCE1B79230Q42706186-BBAFCD46-434A-4153-A545-DE5E023D0404Q42710489-8EB52094-67AE-4AEC-A777-B608701FCD81Q43817839-54B8CA80-AD30-4996-8480-A4951E2DBB31Q43969535-D9B9DBCC-B638-4EB2-972B-1D2C6D126758Q43981823-BA41F832-FA43-4524-822C-DDEF0746924EQ44057665-08A616F4-2F45-4FDE-A6EA-00C3829E3F86Q44251136-CB1F4BB7-9B61-4F76-BB8C-69336E02A4CBQ46301762-5FD125E5-E2F2-42E7-93A7-4C1912B21172Q46776426-0B115183-25BC-49CE-BA95-FC81AA8DF8C4Q48363941-67D44E56-8DC9-456A-8EE2-B6008EA1235DQ48467208-0BF4A9BA-D017-4BD6-A2DB-425F63C0DEBAQ51940650-03F80CDB-4743-4C0F-A8C0-277747084098Q52953264-F1559185-067F-47A8-A554-BBB987BD0039Q57023896-B4D22831-9919-4705-8DF8-1E69923EAB84
P2860
Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Contractile 5-HT1B receptors i ...... tion with immunocytochemistry.
@en
type
label
Contractile 5-HT1B receptors i ...... tion with immunocytochemistry.
@en
prefLabel
Contractile 5-HT1B receptors i ...... tion with immunocytochemistry.
@en
P2093
P2860
P356
P1476
Contractile 5-HT1B receptors i ...... tion with immunocytochemistry.
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0702773
P407
P577
1999-11-01T00:00:00Z